Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals

Vaccine

Volumn 26, Issue 51, 2008, Pages 6645-6654

  Lima Junior, J C ^a   Tran, T M ^b   Meyer, E V S ^b   Singh, B ^b   De Simone, S G ^a   Santos, F ^c   Daniel Ribeiro, C T ^a   Moreno, A ^b,e   Barnwell, J W ^d   Galinski, M R ^b,e   Oliveira Ferreira, J ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b EMORY UNIVERSITY   (United States)

^c LACEN   (Brazil)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Malaria; Merozoite surface protein 9; Plasmodium vivax; Vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 4; MEROZOITE SURFACE PROTEIN 9; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIBODY RESPONSE; ARTICLE; BRAZIL; CELLULAR IMMUNITY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TIME;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; BRAZIL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; MALARIA, VIVAX; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PLASMODIUM VIVAX; PREVALENCE; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 57649162798     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.029     Document Type: Article

References (53)

1. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., and Anstey N.M. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77 December (6 Suppl.) (2007) 79-87
2. Baird J.K. Neglect of Plasmodium vivax malaria. Trends Parasitol 23 November (11) (2007) 533-539
3. Krotoski W.A., Collins W.E., Bray R.S., Garnham P.C., Cogswell F.B., Gwadz R.W., et al. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg 31 November (6) (1982) 1291-1293
4. Canessa A., Mazzarello G., Cruciani M., and Bassetti D. Chloroquine-resistant Plasmodium vivax in Brazil. Trans R Soc Trop Med Hyg 86 September-October (5) (1992) 570-571
5. de Santana Filho F.S., Arcanjo A.R., Chehuan Y.M., Costa M.R., Martinez-Espinosa F.E., Vieira J.L., et al. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13 July (7) (2007) 1125-1126
6. Nayar J.K., Baker R.H., Knight J.W., Sullivan J.S., Morris C.L., Richardson B.B., et al. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys. J Parasitol 83 August (4) (1997) 739-745
7. Polley S.D., McRobert L., and Sutherland C.J. Vaccination for vivax malaria: targeting the invaders. Trends Parasitol 20 March (3) (2004) 99-102
8. Wipasa J., Elliott S., Xu H., and Good M.F. Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 80 October (5) (2002) 401-414
9. Galinski M.R., Medina C.C., Ingravallo P., and Barnwell J.W. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 69 June (7) (1992) 1213-1226
10. Chitnis C.E., and Sharma A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol 24 January (1) (2008) 29-34
11. Tsuboi T., Kappe S.H., al-Yaman F., Prickett M.D., Alpers M., and Adams J.H. Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein. Infect Immun 62 December (12) (1994) 5581-5586
12. Wertheimer S.P., and Barnwell J.W. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol 69 November (4) (1989) 340-350
13. Igonet S., Vulliez-Le Normand B., Faure G., Riottot M.M., Kocken C.H., Thomas A.W., et al. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. J Mol Biol 366 March (5) (2007) 1523-1537
14. Hodder A.N., Crewther P.E., Matthew M.L., Reid G.E., Moritz R.L., Simpson R.J., et al. The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 271 November (46) (1996) 29446-29452
15. del Portillo H.A., Longacre S., Khouri E., and David P.H. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc Natl Acad Sci USA 88 May (9) (1991) 4030-4034
16. Galinski M.R., Corredor-Medina C., Povoa M., Crosby J., Ingravallo P., and Barnwell J.W. Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain. Mol Biochem Parasitol 101 June (1-2) (1999) 131-147
17. Vargas-Serrato E., Barnwell J.W., Ingravallo P., Perler F.B., and Galinski M.R. Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum. Mol Biochem Parasitol 120 March (1) (2002) 41-52
18. Arevalo-Herrera M., Castellanos A., Yazdani S.S., Shakri A.R., Chitnis C.E., Dominik R., et al. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys. Am J Trop Med Hyg 73 November (5 Suppl.) (2005) 25-31
19. Good M.F. Towards a blood-stage vaccine for malaria: are we following all the leads?. Nat Rev Immunol 1 November (2) (2001) 117-125
20. Pombo D.J., Lawrence G., Hirunpetcharat C., Rzepczyk C., Bryden M., Cloonan N., et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360 August (9333) (2002) 610-617
21. Ceravolo I.P., Souza-Silva F.A., Fontes C.J., Braga E.M., Madureira A.P., Krettli A.U., et al. Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission. Scand J Immunol 67 March (3) (2008) 270-278
22. Metzger W.G., Okenu D.M., Cavanagh D.R., Robinson J.V., Bojang K.A., Weiss H.A., et al. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol 25 June (6) (2003) 307-312
23. Nogueira P.A., Alves F.P., Fernandez-Becerra C., Pein O., Santos N.R., Pereira da Silva L.H., et al. A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. Infect Immun 74 May (5) (2006) 2726-2733
24. Okech B.A., Corran P.H., Todd J., Joynson-Hicks A., Uthaipibull C., Egwang T.G., et al. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun 72 March (3) (2004) 1557-1567
25. Barnwell J.W., Galinski M.R., DeSimone S.G., Perler F., and Ingravallo P. Plasmodium vivax, P. cynomolgi, and P. knowlesi: identification of homologue proteins associated with the surface of merozoites. Exp Parasitol 91 March (3) (1999) 238-249
26. Kushwaha A., Rao P.P., Duttu V.S., Malhotra P., and Chauhan V.S. Expression and characterisation of Plasmodium falciparum acidic basic repeat antigen expressed in Escherichia coli. Mol Biochem Parasitol 106 March (2) (2000) 213-224
27. Oliveira-Ferreira J., Vargas-Serrato E., Barnwell J.W., Moreno A., and Galinski M.R. Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli. Vaccine 22 May (15-16) (2004) 2023-2030
28. Pratt-Riccio L.R., Lima-Junior J.C., Carvalho L.J., Theisen M., Espindola-Mendes E.C., Santos F., et al. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria. Am J Trop Med Hyg 73 December (6) (2005) 1096-1103
29. Tran T.M., Oliveira-Ferreira J., Moreno A., Santos F., Yazdani S.S., Chitnis C.E., et al. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Am J Trop Med Hyg 73 August (2) (2005) 244-255
30. Singh H., and Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17 December (12) (2001) 1236-1237
31. Alves F.P., Durlacher R.R., Menezes M.J., Krieger H., Silva L.H., and Camargo E.P. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 66 June (6) (2002) 641-648
32. Coura J.R., Suarez-Mutis M., and Ladeia-Andrade S. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection-a review. Mem Inst Oswaldo Cruz 101 May (3) (2006) 229-237
33. Baird J.K. Age-dependent characteristics of protection V. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 92 June (4) (1998) 367-390
34. Ceravolo I.P., Bruna-Romero O., Braga E.M., Fontes C.J., Brito C.F., Souza J.M., et al. Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. Am J Trop Med Hyg 72 June (6) (2005) 675-681
35. Bouharoun-Tayoun H., Oeuvray C., Lunel F., and Druilhe P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 182 August (2) (1995) 409-418
36. Cavanagh D.R., Dobano C., Elhassan I.M., Marsh K., Elhassan A., Hviid L., et al. Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun 69 February (2) (2001) 1207-1211
37. Topolska A.E., Richie T.L., Nhan D.H., and Coppel R.L. Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection. Infect Immun 72 June (6) (2004) 3325-3330
38. Morais C.G., Soares I.S., Carvalho L.H., Fontes C.J., Krettli A.U., and Braga E.M. IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. Parasitol Res 95 April (6) (2005) 420-426
39. Soares I.S., Levitus G., Souza J.M., Del Portillo H.A., and Rodrigues M.M. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect Immun 65 May (5) (1997) 1606-1614
40. Soares I.S., and Rodrigues M.M. Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted non-glycosylated polypeptide from Pichia pastoris. Parasitology 124 March (Pt3) (2002) 237-246
41. Rodrigues M.H., Rodrigues K.M., Oliveira T.R., Comodo A.N., Rodrigues M.M., Kocken C.H., et al. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int J Parasitol 35 February (2) (2005) 185-192
42. Morais C.G., Soares I.S., Carvalho L.H., Fontes C.J., Krettli A.U., and Braga E.M. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity. Am J Trop Med Hyg 75 October (4) (2006) 582-587
43. Soares I.S., Oliveira S.G., Souza J.M., and Rodrigues M.M. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil. Acta Trop 72 January (1) (1999) 13-24
44. Braga E.M., Barros R.M., Reis T.A., Fontes C.J., Morais C.G., Martins M.S., et al. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am J Trop Med Hyg 66 May (5) (2002) 461-466
45. Scopel K.K., Fontes C.J., Ferreira M.U., and Braga E.M. Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia. Clin Vaccine Immunol 13 July (7) (2006) 810-813
46. Aucan C., Traore Y., Tall F., Nacro B., Traore-Leroux T., Fumoux F., et al. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect Immun 68 March (3) (2000) 1252-1258
47. Fell A.H., Currier J., and Good M.F. Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8 + T cells from non-exposed donors. Parasite Immunol 16 November (11) (1994) 579-586
48. Hviid L., Theander T.G., Jakobsen P.H., Abu-Zeid Y.A., Abdulhadi N.H., Saeed B.O., et al. Cell-mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan. Apmis 98 July (7) (1990) 594-604
49. Ramharter M., Willheim M., Winkler H., Wahl K., Lagler H., Graninger W., et al. Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients. Parasite Immunol 25 April (4) (2003) 211-219
50. Theander T.G., Hviid L., Dodoo D., Afari E.A., Jensen J.B., and Rzepczyk C.M. Human T-cell recognition of synthetic peptides representing conserved and variant sequences from the merozoite surface protein 2 of Plasmodium falciparum. Immunol Lett 58 June (1) (1997) 1-8
51. Troye-Blomberg M., Riley E.M., Kabilan L., Holmberg M., Perlmann H., Andersson U., et al. Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci USA 87 July (14) (1990) 5484-5488
52. Farouk S.E., Dolo A., Bereczky S., Kouriba B., Maiga B., Farnert A., et al. Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali. Microbes Infect 7 January (1) (2005) 110-117
53. al-Yaman F., Genton B., Taraika J., Anders R., and Alpers M.P. Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area. Parasite Immunol 19 June (6) (1997) 249-254